Live Chat

Trade BioNTech BNTX

Sell
 Buy

BioNTech live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

News

Webhose 2024 Dec 16, 21:52

BioNTech (NASDAQ:BNTX) Shares Down 2.3% - Time to Sell?

BioNTech SE
Webhose 2024 Dec 15, 20:52

BioNTech's SWOT analysis: mRNA pioneer's stock faces oncology pipeline test By Investing.com

BioNTech SE
Webhose 2024 Dec 15, 01:18

BioNTech (NASDAQ:BNTX) and Senti Biosciences (NASDAQ:SNTI) Critical Analysis

BioNTech SE
Webhose 2024 Dec 14, 14:38

BioNTech (NASDAQ:BNTX) Shares Up 1.3% – Here’s What Happened

BioNTech SE
Webhose 2024 Dec 14, 12:27

Exome Asset Management LLC Takes Position in BioNTech SE (NASDAQ:BNTX)

BioNTech SE
Webhose 2024 Dec 14, 09:41

Y Intercept Hong Kong Ltd Invests $718,000 in BioNTech SE (NASDAQ:BNTX)

BioNTech SE
Webhose 2024 Dec 14, 02:11

BioNTech Says FDA Lifted Partial Hold on Lung Cancer Study

BioNTech SE
Webhose 2024 Dec 13, 21:15

BioNTech says partial clinical hold on BNT316 study lifted

BioNTech SE
Webhose 2024 Dec 13, 19:34

BioNTech (NASDAQ:BNTX) Stock Price Down 1.6% - Here's What Happened

BioNTech SE
Webhose 2024 Dec 13, 13:06

BioNTech SE : FDA has lifted partial clinical hold on PRESERVE-003 trial By Investing.com

BioNTech SE
Webhose 2024 Dec 13, 10:34

Vestcor Inc Takes Position in BioNTech SE (NASDAQ:BNTX)

BioNTech SE
Webhose 2024 Dec 13, 08:41

Captrust Financial Advisors Sells 8,909 Shares of BioNTech SE (NASDAQ:BNTX)

BioNTech SE
Webhose 2024 Dec 12, 19:14

BioNTech (NASDAQ:BNTX) Stock Price Up 1.3% - Time to Buy?

BioNTech SE
Webhose 2024 Dec 12, 11:42

BioNTech (NASDAQ:BNTX) Now Covered by Wells Fargo & Company

BioNTech SE
Webhose 2024 Dec 11, 20:44

BioNTech (NASDAQ:BNTX) Stock Price Up 2.7% - Here's What Happened

BioNTech SE
Webhose 2024 Dec 11, 13:13

BioNTech (NASDAQ:BNTX) Now Covered by Analysts at Wells Fargo & Company

BioNTech SE
Webhose 2024 Nov 18, 07:31

FY2024 EPS Estimates for BioNTech Decreased by Analyst

BioNTech SE

Latest news

Frances Wang 2024 Dec 17, 16:00

Nikkei 225 performance today: Beginner’s guide to Japan’s stock market

Indices Stocks
Frances Wang 2024 Dec 16, 16:00

MicroStrategy Stock Price: MSTR stock saw an increase of 0.15% today

Stocks
Frances Wang 2024 Dec 16, 16:00

Gold price today: gold holds two-day decline ahead of Fed rate cut

Commodities Gold
Frances Wang 2024 Dec 16, 16:00

Latest cryptocurrency news: What is bitcoin, Ethereum explained

Cryptocurrencies
Frances Wang 2024 Dec 15, 16:00

Broadcom stock price soars 23% as AI revenues spike 220%

Stocks
Dyogenes Diniz 2024 Dec 15, 16:00

Morning Note: Tesla Hits Record High Amid US PMI Focus and Bitcoin's Next Move

Cryptocurrencies US500 EUR USD
US interest rate and Europe inflation to guide market direction
Dyogenes Diniz 2024 Dec 13, 22:00

Week ahead: US Interest rate and Inflation in Europe to determine Markets Direction - Crucial Week

Forex Indices
Frances Wang 2024 Dec 12, 16:00

Elon Musk Net Worth Over $400 Billion as Tesla Stock Hits New Highs

TSLA

Info

Spread

0.8547

Spread (%)

0.7304 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Wednesday

14:31 - 20:59

Monday

14:31-20:59

Tuesday

14:31-20:59

Thursday

14:31-20:59

Friday

14:31-20:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

27383103488

Shares Outstanding

239740000

Earnings Date (Next)

0000-00-00

Div Yield

2022-06-17

Ex-Dividend Date

2022-06-02

Forward annual dividend rate

0

Forward annual dividend yield

0

EPS

-1.93

Learn more about this instrument

BioNTech BioNTech SE
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II clinical trial to treat HPV 16+ head and neck cancers; BNT114 to treat triple negative breast cancer; BNT115, which is in Phase I clinical trial in ovarian cancer; and BNT116, which is in Phase I clinical trial for non-small cell lung cancer. It develops BNT122, which is in Phase II clinical trial for first-line melanoma and in Phase I clinical trial to treat multiple solid tumors; BNT131 that is in Phase I clinical trial for multiple solid tumors; BNT141 and BNT142 that are in Phase I clinical trial to treat multiple solid tumors; BNT151, BNT152, and BNT153 to treat solid tumors; BNT211 to treat multiple solid tumors, and BNT221 for pancreatic and other cancers; BNT311 which are in Phase II clinical trial to treat metastatic non-small cell lung cancer and Phase I/II clinical trial to treat multiple solid tumors; and BNT312, which is in Phase 2 clinical trial to treat multiple solid tumors, as well as ONC-392, which is in Phase III clinical trial to treat ovarian cancer and Phase I/II clinical trial to treat multiple solid tumors. It develops BNT321, an IgG1 monoclonal antibody in Phase I clinical trial for pancreatic cancer; BNT411, a small molecule immunomodulator product candidate in Phase I clinical trial for solid tumors; BNT322, which is in Phase I/Ib clinical trial for multiple solid tumors; and prophylactic vaccine for shingles, malaria, tuberculosis, HSV-2, and other infectious diseases. It has collaborations with Genentech, Inc.; Sanofi S.A.; Genmab A/S; Pfizer Inc.; Shanghai Fosun Pharmaceutical (Group) Co., Ltd; and Ryvu Therapeutics S.A, as well as strategic partnership the Coalition for Epidemic Preparedness Innovations (CEPI) to strengthen africa's mrna vac

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments
Trustpilot
Live Chat